Results 11 to 20 of about 11,998,196 (407)

COPD and Cardiovascular Disease [PDF]

open access: yesPulmonology, 2019
COPD is one of the major public health problems in people aged 40 years or above. It is currently the 4th leading cause of death in the world and projected to be the 3rd leading cause of death by 2020. COPD and cardiac comorbidities are frequently associated.
André, S.   +5 more
openaire   +11 more sources

The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease

open access: yesNature Reviews Cardiology, 2022
The death of terminally differentiated cardiomyocytes is an important pathogenic contributor to the development of several forms of cardiovascular disease.
X. Fang, H. Ardehali, J. Min, Fudi Wang
semanticscholar   +1 more source

Adiponectin gene expression in local fat depots in patients with coronary heart disease depending on the degree of coronary lesion

open access: yesТерапевтический архив, 2020
Aim. To determine the dependence of adiponectin gene expression by subcutaneous, epicardial and perivascular adipocytes on the degree of coronary lesion in coronary heart disease. Materials and methods.
E. V. Belik   +13 more
doaj   +1 more source

Association of epicardial fat thickness with left ventricular diastolic function parameters in a community population

open access: yesBMC Cardiovascular Disorders, 2021
Background We examined the relationship between epicardial fat thickness (EFT) measured by echocardiography and left ventricular diastolic function parameters in a Beijing community population.
Wei Ma   +8 more
doaj   +1 more source

Effect of sodium-glucose cotransporter-2 inhibitors on blood pressure in patients with heart failure: a systematic review and meta-analysis

open access: yesCardiovascular Diabetology, 2022
Background Recent studies have shown that sodium-glucose cotransporter-2 inhibitors (SGLT2i) can achieve significant improvement in blood pressure in people with diabetes. Furthermore, randomized controlled trials (RCTs) have established that SGLT2i have
Min Li   +8 more
doaj   +1 more source

Social Determinants of Cardiovascular Disease

open access: yesCirculation Research, 2022
Social determinants of health (SDoH), which encompass the economic, social, environmental, and psychosocial factors that influence health, play a significant role in the development of cardiovascular disease (CVD) risk factors as well as CVD morbidity ...
T. Powell-Wiley   +9 more
semanticscholar   +1 more source

Acknowledgement to Reviewers of Journal of Cardiovascular Development and Disease in 2018

open access: yesJournal of Cardiovascular Development and Disease, 2019
Rigorous peer-review is the corner-stone of high-quality academic publishing[...]
Journal of Cardiovascular Development and Disease Editorial Office
doaj   +1 more source

Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu

open access: yesScientific Reports, 2020
Hyperuricemia is a risk factor for cardiovascular metabolic diseases. However, in the very elderly, the relationship between hyperuricemia and the metabolic syndrome (MetS) is not yet clear.
Gang Huang   +6 more
doaj   +1 more source

Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

open access: yesNew England Journal of Medicine, 2020
Background Coronavirus disease 2019 (Covid-19) may disproportionately affect people with cardiovascular disease. Concern has been aroused regarding a potential harmful effect of angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor ...
M. Mehra   +4 more
semanticscholar   +1 more source

Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease

open access: yesCell Death and Disease, 2022
Mitochondria are highly dynamic organelles that participate in ATP generation and involve calcium homeostasis, oxidative stress response, and apoptosis.
Anqi Li   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy